Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/23/2018 |
| Start Date: | May 1999 |
| End Date: | December 2050 |
| Contact: | Julie A Ward, BSN |
| Email: | wardj@upmc.edu |
| Phone: | 412-647-8583 |
To assess short and long term outcomes after minimally invasive esophagectomy compared to
open esophagectomy. To compare both standard outcome measures as well as patient derived
outcome measures, in particular, quality of life (QOL). To look at the applicability of this
QOL instrument to this patient group.
open esophagectomy. To compare both standard outcome measures as well as patient derived
outcome measures, in particular, quality of life (QOL). To look at the applicability of this
QOL instrument to this patient group.
Assess short and long term outcomes after minimally invasive esophagectomy(MIE) compared to
open esophagectomy. Measure standard observer derived outcomes such as morbidity, mortality,
tumor recurrence and also patient derived outcomes, in particular quality of life (QOL) using
the MOS SF36 questionnaire. Evaluate whether the SF36 will accurately reflect pre and
postoperative changes in clinical status in this patient group.Compare the results of this
global QOL instrument (SF 36) to disease specific scales of dysphagia and reflux. Assess the
impact of adjuvant or neoadjuvant therapy on QOL in this patient group and determine if any
advantages of MIE can be demonstrated.
open esophagectomy. Measure standard observer derived outcomes such as morbidity, mortality,
tumor recurrence and also patient derived outcomes, in particular quality of life (QOL) using
the MOS SF36 questionnaire. Evaluate whether the SF36 will accurately reflect pre and
postoperative changes in clinical status in this patient group.Compare the results of this
global QOL instrument (SF 36) to disease specific scales of dysphagia and reflux. Assess the
impact of adjuvant or neoadjuvant therapy on QOL in this patient group and determine if any
advantages of MIE can be demonstrated.
Inclusion Criteria:
- Patients scheduled for MIE (Minimally Invasive Esophagectomy)
- Patients scheduled for open esophagectomy
- Signed informed consent
Exclusion Criteria:
- Patients who are unable to comprehend or complete the QOL instruments.
- Patients less than 18 years of age.
We found this trial at
2
sites
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15213
Principal Investigator: James D. Luketich, MD
Phone: 412-647-8583
Click here to add this to my saved trials